Delivery Order SPE2DB20D7059-SPE2DB25FQLY1
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,046.81 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Atropine 1 mg/mL vials. This is a firm fixed price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location and an ultimate completion date of July 21, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Atropine 1 mg/mL vials. This firm fixed price delivery order, valued at $1,339.21, represents a non-competitive award and is set to be completed by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1.74K to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Atropine 8 mg/20 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract. This delivery order falls...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $3,057.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine Sulfate Injectable. This non-set-aside, competitively awarded contract was issued on February 16, 2024, with an ultimate completion date of February 20, 2024, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under a larger...
- This federal contract award is a delivery order valued at $2,241.04, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATROPINE 0.4 MG/ML VIAL, a medical product, with a period of performance running through July 11, 2025. The contract is designated as a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition....
- This is a $3,231.83 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of Atropine 8 mg/20 ml vials, a critical medication used in the treatment of organophosphate poisoning. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Atropine 8mg/20ml medication. The order has a potential value of $2,727.67 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation or larger contract vehicle. Amerisourcebergen Drug Corp, a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide Atropine 1 mg/mL vials. The $21,780.88 contract has a completion date of March 1, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor...
- The Defense Logistics Agency Troop Support Medical awarded a $12,260.79 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 mg/ml atropine vials. The single order is for product delivery to a location in Conshohocken, Pennsylvania by July 7, 2023. No additional details were provided regarding the original solicitation requirements or whether this award is associated with any broader indefinite delivery/indefinite quantity contracts held by Amerisourcebergen. As the...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,922.61 firm fixed-price delivery order is for the supply of ATROPINE 1 MG/ML VIALML, a critical medical product, with a performance period through March 6, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQLY1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,849.28 to AmerisourceBergen Drug Corp on July 22, 2025, for Atropine 0.4 mg/mL vials. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. Atropine is a critical emergency medical supply used primarily as an antidote for nerve agent and organophosphate poisoning, making it essential for military medical readiness and contingency preparedness. This delivery order operates under AmerisourceBergen's larger $999.99 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor with significant federal contracting experience, AmerisourceBergen fulfills critical medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award reflects the company's established capability to provide specialized pharmaceutical commodities on-demand to support DOD operations and readiness requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/22/25 |